Table 2. Results at 52 weeks.

	<0.30	0.30–0.59	0.60–0.99	1.00–1.20	All eyes
Mean no. of Rx (including three loading doses)	5.4	5.6	5.8	5.2	5.6
Mean letter gain	−0.5	2.2	6.5	15.3	5.5
Mean BCVA	0.20	0.37	0.60	0.76	0.49
<15 letter loss	0.93	0.88	0.92	1.00	0.92
>15 letter gain	0.01	0.16	0.33	0.46	0.24

Abbreviation: BCVA, best-corrected visual acuity; Rx, ranibizumab intravitreal injections.